EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico analysis to explore the therapeutic potential of propolis-derived small molecules as matriptase inhibitors to suppress breast cancer growth and metastasis

Muhammad Bilal Azmi iD, Han Yu iD, Arisha Sohail, Uzma Asif iD, Syed Danish Haseen Ahmed, Shamim Akhtar Qureshi, Mohnad Abdalla

PLOS One · 2025

DOI: 10.1371/journal.pone.0321687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Muhammad Bilal Azmi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Computational Biochemistry Research Laboratory, Department of Biochemistry, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan. Hauptthemen laut MEDLINE: Breast Neoplasms, Propolis, Serine Endopeptidases, Antineoplastic Agents. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a major cause of death in women, and various drug therapies are used for its treatment. However, current therapies have many side effects and limitations. Propolis, a resinous product of bee hives, possesses a variety of biological activities, including anticancer and chemo-protective properties. The present study aimed to investigate the potential suitability of propolis-derived compounds to inhibit matriptase (MT-SP1), a potential protein target for breast cancer treatment, through comprehensive computational analysis. The MT-SP1 protein structure (PDB ID: 1EAX) was retrieved, energy-minimized, and validated. Five propolis-derived compounds with the highest binding energies to MT-SP1 were selected after virtual screening. Molecular docking of these selected ligands revealed binding energies ranging from -8.4 to -9.1 kcal/mol. Stable complex formation was validated by an additional 250 ns of molecular dynamics simulations. The HOMO-LUMO and DFT characteristics provided further evidence of the chemical reactivity and stability of these five ligands at the MT-SP1 active site. Screening of compounds for drug-likeness, pharmacokinetics (ADMET profiles), and toxicity identified two promising small molecules (PubChem IDs of ligands 72307 and 129827386) as potential drug candidates for inhibiting MT-SP1. However, experimental validation through in vitro or in vivo studies is necessary to confirm these computational findings and explore their therapeutic potential for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPropolisSerine EndopeptidasesAntineoplastic AgentsEnzyme InhibitorsSmall Molecule LibrariesHumansFemaleMolecular Docking SimulationMolecular Dynamics SimulationNeoplasm MetastasisComputer SimulationCell ProliferationLigands

Substanzen

PropolisSerine EndopeptidasesAntineoplastic AgentsmatriptaseLigandsEnzyme InhibitorsSmall Molecule Libraries

Autor:innen und Institutionen

  • Computational Biochemistry Research Laboratory, Department of Biochemistry, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
  • Children's Hospital Affiliated to Shandong University, Jinan, China.
  • Jinan Children's Hospital, Jinan, China.
  • Department of Computational Biology, School of Life Sciences, Fudan University, Shanghai, China.
  • Department of Biochemistry, Medicine Program, Batterjee Medical College, Jeddah, Saudi Arabia.
  • Department of Biochemistry, University of Karachi, Karachi, Pakistan.

ORCID-Profile: Muhammad Bilal Azmi, Han Yu, Uzma Asif

Zitieren

APA

Azmi, M. B., Yu, H., Sohail, A., Asif, U., Ahmed, S. D. H., Qureshi, S. A., & Abdalla, M. (2025). In silico analysis to explore the therapeutic potential of propolis-derived small molecules as matriptase inhibitors to suppress breast cancer growth and metastasis. PLOS One. https://doi.org/10.1371/journal.pone.0321687

Vancouver

Azmi MB, Yu H, Sohail A, Asif U, Ahmed SDH, Qureshi SA, et al. In silico analysis to explore the therapeutic potential of propolis-derived small molecules as matriptase inhibitors to suppress breast cancer growth and metastasis. PLOS One. 2025. doi:10.1371/journal.pone.0321687

BibTeX
@article{Azmi2025,
  author = {Azmi, Muhammad Bilal and Yu, Han and Sohail, Arisha and Asif, Uzma and Ahmed, Syed Danish Haseen and Qureshi, Shamim Akhtar and Abdalla, Mohnad},
  title = {In silico analysis to explore the therapeutic potential of propolis-derived small molecules as matriptase inhibitors to suppress breast cancer growth and metastasis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0321687}
}
Kostenlos starten →